Q32 Share Price

Q32 Share Price

NASDAQ: QTTB | Micro Cap | Healthcare
$8.36
-$0.12 (-1.42%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Q32 Stock Performance

Open
$8.30
Prev. Close
$8.48
Circuit Range
N/A
Day Range
$8.22 - $8.56
Year Range
$1.92 - $23.38
Volume
23,186
Average Traded
$8.43

Q32 Share Price Today

As of 21 November 2026, Q32 Bio Inc.'s share price is $8.36. The stock opened at $8.30, compared to its previous close of $8.48. During today's trading session, Q32 Bio Inc.'s share price traded between $8.22 and $8.56, with an average price of $8.39. Over the past 52 weeks, the stock has recorded a high of $23.38 and a low of $1.92. In terms of performance, Q32 Bio Inc.'s share price has declined by 24.48% over the last six months and is up 283.49% on a year-on-year basis.

Q32 Share Price Chart

Line chart of the Q32 price trend over the selected period. The price fell overall, ranging from 8.22 to 8.57, ending at 8.35.
$8.22$8.56
L
Show Current Price
H

Q32 Stock Fundamentals & Key Indicators

Market Cap
$102.83M
PE Ratio (TTM)
7.87
Dividend Yield
0.00%
EPS (TTM)
$1.08
Revenue (TTM)
$53.74B
Return On Equity (TTM)
11.21%
Profit Margin
55.49%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-115.45%

Q32 Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$53.74$0.00$0.00$0.00
Net Profit$57.73-$7.61-$8.95-$8.92
Net Profit Margin107.42%N/AN/AN/A
Income ChangeN/A-113.18%-17.61%0.34%

Q32 Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$53.74
Net Profit-$47.73$29.82
Net Profit MarginN/A55.49%
Income ChangeN/A162.48%

Q32 Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets6.7310.46
Current Assets55.0581.88
Total Assets61.7892.33
Non Current Liabilities8.4270.19
Current Liabilities11.3516.47
Total Liabilities19.7686.66
Shareholders' Equity42.015.68

Q32 Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-33.54-67.72
Investing7.019.93
Financing-3.1395.14

About Q32

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Q32 Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.78
$8.36
-6.75%
Oct 2026
$8.36
$8.96
+8.67%
Sep 2026
$14.49
$8.25
-48.93%
Aug 2026
$15.06
$16.16
+3.13%
Jul 2026
$12.72
$15.66
+22.77%
Jun 2026
$11.81
$12.76
+15.27%
May 2026
$5.46
$11.07
+95.58%
Apr 2026
$6.61
$5.66
-11.01%
Mar 2026
$4.80
$6.36
+39.17%
Feb 2026
$3.95
$4.57
+15.70%
Jan 2026
$3.28
$3.95
+20.43%
Dec 2025
$4.24
$3.28
+50.46%

Q32 Share Price FAQs